Literature DB >> 44310

Serotypes of Streptococcus pneumoniae causing disease.

B M Gray, G M Converse, H C Dillon.   

Abstract

Serotypes of Streptococcus pneumoniae from 525 infected children were examined over a four-year period. Type distribution was similar among 84 cases of bacteremia and 30 cases of meningitis, with types 6, 14, and 18 accounting for half of the illnesses. In contrast, half of 396 episodes of otitis media were caused by three other types, 19, 23, and 3. Four of eight fatalities were due to type 6. Carrier strains isolated from children had a distribution of types similar to that of the otitis media collection. Adult patients had fewer of the types that caused disease in children. Most childhood infections (80%) occurred in children less than or equal to 24 months of age; no relationship between age and infecting serotype was noted. There were no seasonal trends in type distribution.

Entities:  

Mesh:

Year:  1979        PMID: 44310     DOI: 10.1093/infdis/140.6.979

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.

Authors:  B Simell; T Kilpi; H Käyhty
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

2.  Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.

Authors:  S L Harris; M K Park; M H Nahm; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Authors:  W T Jansen; S Hogenboom; M J Thijssen; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe; A F Verheul
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Pneumococcosuria in children.

Authors:  M A Miller; B S Kaplan; S Sorger; K F Knowles
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

5.  Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity.

Authors:  J E Schweinle
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

6.  Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.

Authors:  E Alonso de Velasco; A F Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Overwhelming pneumococcal infection in a hyposplenic adult.

Authors:  J P Hatch; W J Sibbald; T W Austin
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

8.  A comparison of the distribution of pneumococcal types in systemic disease and the upper respiratory tract in adults and children.

Authors:  L E Smart; D J Platt; M C Timbury
Journal:  Epidemiol Infect       Date:  1987-04       Impact factor: 2.451

9.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

Authors:  B M Gray; H C Dillon; D E Briles
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.

Authors:  J M Dixon; A E Lipinski
Journal:  Can Med Assoc J       Date:  1981-08-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.